Home » Topics » Regulatory » NMPA

NMPA
RSS

U.S. and China IND clearances for Ascentage's APG-1252

Dec. 28, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Oct. 21, 2016

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

Cervarix approved in China

July 18, 2016

CFDA approves Roche's CINtec PLUS Cytology test

March 9, 2016

3SBio obtains IND clearance in China for PEG-irinotecan

March 7, 2016

Tapros approved for open-angle glaucoma and ocular hypertension in China

Aug. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026